These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26152)

  • 1. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
    Brunner H
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current problems in active substance research. 4. Central effects of angiotensin II].
    Hilse H; Piesche L; Scheer E
    Pharmazie; 1974 May; 29(5):303-6. PubMed ID: 4152657
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta adrenoceptor blocking drugs in hypertension.
    Turner P
    Clin Invest Med; 1978; 1(3-4):129-33. PubMed ID: 42502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
    Bühler FR
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1798-806. PubMed ID: 13490
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
    Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE
    J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive therapy using beta receptor blockers].
    Meurer KA
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2161-2. PubMed ID: 240664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-blocking agents in essential hypertension].
    Sakaguchi A; Ikeda M
    Nihon Rinsho; 1979 Oct; 37(10):3499-502. PubMed ID: 42818
    [No Abstract]   [Full Text] [Related]  

  • 14. The editor's roundtable: revisiting the role of beta blockers in hypertension.
    Roberts WC; Black HR; Bakris GL; Mason RP; Giles TD; Sulkes DJ
    Am J Cardiol; 2007 Jul; 100(2):253-67. PubMed ID: 17631080
    [No Abstract]   [Full Text] [Related]  

  • 15. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
    Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
    Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta receptor blockaders in the treatment of hypertension].
    Lohmöller G; Lydtin H
    Med Klin; 1976 Nov; 71(47):2051-7. PubMed ID: 12458
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of arterial hypertension in children (author's transl].
    Balboa de Paz F; Rubio Roldán LA; Sánchez Díaz JI
    An Esp Pediatr; 1981 Dec; 15(6):573-80. PubMed ID: 6121529
    [No Abstract]   [Full Text] [Related]  

  • 18. [Propranolol therapy in hypertension].
    Krediet RT
    Ned Tijdschr Geneeskd; 1978 May; 122(21):761-5. PubMed ID: 349413
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurogenic hypertension, with special reference to the central neurogenic effects of angiotensin.
    Dickinson CJ
    Circ Res; 1970 Oct; 27():Suppl 2:169+. PubMed ID: 4319093
    [No Abstract]   [Full Text] [Related]  

  • 20. The essential action of propranolol in hypertension.
    Lewis P
    Am J Med; 1976 May; 60(6):837-52. PubMed ID: 14498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.